Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
68,958,635
-
Total 13F shares
-
34,813,365
-
Share change
-
+34,812,865
-
Total reported value
-
$1,644,705,008
-
Price per share
-
$48.08
-
Number of holders
-
55
-
Value change
-
+$1,644,681,092
-
Number of buys
-
54
Institutional Holders of Olema Pharmaceuticals, Inc. - Common Stock (OLMA) as of Q4 2020
As of 31 Dec 2020 Olema Pharmaceuticals, Inc. - Common Stock (OLMA) had 55 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 34,813,365 shares of stock of the company.
Largest 10 holders included BVF INC/IL, Logos Global Management LP, JANUS HENDERSON GROUP PLC, Cormorant Asset Management, LP, RA CAPITAL MANAGEMENT, L.P., WELLINGTON MANAGEMENT GROUP LLP, VR Adviser, LLC, CITADEL ADVISORS LLC, Vivo Capital, LLC, and Avoro Capital Advisors LLC.
This table shows 55 institutional shareholders of the security as of 31 Dec 2020.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.